Source link : https://newshealth.biz/health-news/fda-approves-maintenance-combo-for-small-cell-lung-cancer/

(MedPage Today) — The FDA approved lurbinectedin (Zepzelca) plus either atezolizumab (Tecentriq) or atezolizumab and hyaluronidase (Tecentriq Hybreza) as first-line maintenance therapy for extensive-stage small cell lung cancer, the agency announced… Source link : https://www.medpagetoday.com/hematologyoncology/lungcancer/117793 Author : Publish date : 2025-10-03 19:18:00 Copyright for syndicated content belongs to the linked Source.

The post FDA Approves Maintenance Combo for Small Cell Lung Cancer first appeared on News Health.

—-

Author : News Health

Publish date : 2025-10-03 19:18:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678

Exit mobile version